Payal Kohli, MD

In this older patient with T2DM, HFpEF, and other comorbidities, which class of medication is most appropriate--and guideline-recommended?

The new "sweet spot" in diabetes management is the interdisciplinary approach that is essential to treating all aspects of the disease. New diabetes medications also hit that spot.

Evidence-based revisions to the AHA/ACC/HRS guidelines will affect management of your patients with atrial fibrillation. Do you know how? Find out with a quick quiz.

The popular CHA2DS2-Vasc stroke risk calculator has its detractors. But will a newly proposed scoring system have a significant clinical impact?

Right atrial ablation for atrial flutter is associated with a surprisingly high rate of serious, sometimes fatal, complications. News from ESC 2018.

The future role of aspirin in primary prevention of cardiovascular disease is unclear, and not for lack of scrutiny at ESC 2018.

The patient is an elderly man with ESRD on dialysis who goes into atrial fibrillation during fistula declotting. How to proceed?

A new study clears up a lingering question about the novel oral anticoagulants, VKAs, and risk of MI.

A 76-year-old woman with drug eluting stent placed post-STEMI will need an antiplatelet regimen. What would you recommend?

Results of the largest study to assess impact of left atrial appendage closure during routine non-AF-related cardiac surgery raise a few new questions.  

A small single-center study yields provocative results that may help increase understanding of the importance of the left atrial appendage. 

Which CVD biomarker is most useful in what situation? Here are the top 5 most useful in primary care plus 3 key criteria to help choose the right one. 

A topline review of 3 more of the top 6 studies of 2017 in afib includes the death of digoxin, go and no-go foods, and afib and ESRD.   

Cardiologist and Patient Care author Payal Kohli, MD offers snap shots of 6 influential studies that will affect the future of AF diagnosis and treatment.

Bleeding and "mysterious" sginal for MI seen in RE-LY persist. Message: continue to weigh risk vs benefit. 

Study net-net: Account for kidney function when dosing the direct oral anticoagulants -- but also account for an agent's potential renal harm.

Is this patient, status post motor vehicle accident, at risk for developing atrial fibrillation?

You're finishing rounds on Friday and are called to the ICU to consult on a case of Afib. The patient is a surprise and the residents have questions. Good luck!

Which drugs taken concurrently with the new oral anticoagulants put patients with Afib at greatest increased risk for major bleeding?

A first-of-its-kind study reports an association between T1DM and AF, and between glycemic control and AF. Plus, there are gender differences.

That depends, as suggested by results of the CASTLE-AF study, presented at ESC Congress 2017, in Barcelona, Spain.

Diagnosis of atrial fibrillation via handheld iECG monitor looks promising but can we pay for it yet?

A small study raises big questions about patients' perceptions of AF symptoms after pulmonary vein ablation. What do you think?

Increased detection of subclinical atrial fibrillation intensifies a common clinical quandary in AF patients: to anticoagulate, or not?

Rhythm vs rate control and which medication(s) for which patients, when, and why? Test yourself.

Medicine is finally catching up with the smartphone/smartwatch era – and it’s about time!

Does coffee increase AF risk? How about chocolate? Marijuana? Test yourself with our quiz so you can counsel your patients.

Mr Smith is 66-years-old. How would you treat his arrhythmia? What would you choose for anticoagulation?

Digoxin is used in nearly 30% of patients with AF but has never been studied for safety/efficacy in this population, until now.

Some call this new study a "game changer" when it comes to AF patient selection for direct-acting oral anticoagulant Rx. What's your take?